{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:40:20Z","timestamp":1772628020566,"version":"3.50.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>The Binding Site immunonephelometric (IN) IgG subclass reagents (IgG1, IgG2, IgG3, IgG, BSIN) are used for assessment of both immunodeficiency and IgG4-related disease (IgG4-RD). In our laboratory, suspected analytic errors were noted in patients with increases in IgG4: The sum of the individual IgG subclasses was substantially greater than the measured total IgG concentrations (unlike samples with normal IgG4), and the IgG4 concentration was always less than the IgG2 concentration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We developed a tryptic digest LC-MS\/MS method to quantify IgG1, IgG2, IgG3, and IgG4 in serum. Samples with IgG4 concentrations ranging from &amp;lt;0.03 g\/L to 32 g\/L were reanalyzed by LC-MS\/MS, and a subset was also reanalyzed by Siemens IN (SIN) subclass measurements.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Multivariate linear regression identified 3 subclass tests with multiple predictors of the measured subclass concentration. For these 3 subclasses, the predominant predictors were (in terms of LC-MS\/MS IgG subclass measurement coefficients) BSIN IgG1 = 0.89\u00b7IgG1 + 0.4\u00b7IgG4; BSIN IgG2 = 0.94\u00b7IgG4 + 0.89\u00b7IgG2; and SIN IgG2 = 0.72\u00b7IgG2 + 0.24\u00b7IgG4.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>There is apparent IgG4 cross-reactivity with select IN subclass measurements affecting tests from both vendors tested. These findings can be explained either by direct cross-reactivity of the IN reagents with the IgG4 subclass or unique physicochemical properties of IgG4 that permit nonspecific binding of IgG4 heavy chain to other IgG immunoglobulin heavy chains. Irrespective of the mechanism, the observed intermethod discrepancies support the use of LC-MS\/MS as the preferred method for measurement of IgG subclasses when testing patients with suspected IgG4-RD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2017.282319","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T14:25:11Z","timestamp":1516371911000},"page":"735-742","source":"Crossref","is-referenced-by-count":38,"title":["Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS\/MS"],"prefix":"10.1093","volume":"64","author":[{"given":"Grace","family":"van der Gugten","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari L","family":"DeMarco","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC, Canada"},{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke Y C","family":"Chen","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"},{"name":"Division of Hematology, Vancouver General Hospital, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Chin","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Calgary Laboratory Services, Calgary, AB, Canada"},{"name":"Cumming School of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mollie","family":"Carruthers","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"},{"name":"Division of Rheumatology, Vancouver General Hospital, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T","family":"Holmes","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC, Canada"},{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Mattman","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC, Canada"},{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"2020022605560144500_B1","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2020022605560144500_B2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"2020022605560144500_B3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"2020022605560144500_B4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020022605560144500_B5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.38668","article-title":"Calibration differences and the prozone phenomenon in IgG4-related disease: comment on the article by Khosroshahi et al","volume":"66","author":"Parker","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020022605560144500_B6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.clinbiochem.2014.03.018","article-title":"Total IgG method insensitivity to the presence of IgG4 immunoglobulins","volume":"47","author":"Mattman","year":"2014","journal-title":"Clin Biochem"},{"key":"2020022605560144500_B7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1373\/clinchem.2014.222208","article-title":"Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography\u2013tandem mass spectrometry","volume":"60","author":"Ladwig","year":"2014","journal-title":"Clin Chem"},{"key":"2020022605560144500_B8","unstructured":"Wang\n              J\n            , ZamarR, MarazziA, YohaiV, Salibian-BarreraM, MaronnaR, et al. Port of the S+ \u201crobust library\u201d version 0.4-18; https:\/\/CRAN.R-project.org\/package=robust. Accessed on September, 2017."},{"key":"2020022605560144500_B9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clinbiochem.2017.09.004","article-title":"IgG subclasses quantitation: analytical performance of the binding site SPAPLUS(R) human assay and comparison with Siemens BNII(R) assay","volume":"51","author":"Sarnago","year":"2018","journal-title":"Clin Biochem"},{"key":"2020022605560144500_B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22146","article-title":"Similar but not consistent: revisiting the pitfalls of measuring IgG subclasses with different assays","volume":"31","author":"Ludwig-Kraus","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"2020022605560144500_B11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amjms.2017.08.014","article-title":"Utility of serum IgG4 levels in a multiethnic population","volume":"355","author":"Qi","year":"2018","journal-title":"Am J Med Sci"},{"key":"2020022605560144500_B12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/art.38663","article-title":"Corroboration of the prozone phenomenon in IgG4-related disease: comment on the article by Khosroshahi et al","volume":"66","author":"Urquhart","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2020022605560144500_B13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0036-1584322","article-title":"The immunobiology of immunoglobulin G4","volume":"36","author":"Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"key":"2020022605560144500_B14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-3083.2009.02353.x","article-title":"A novel heterophilic antibody interaction involves IgG4","volume":"71","author":"Ito","year":"2010","journal-title":"Scand J Immunol"},{"key":"2020022605560144500_B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ab.2011.01.001","article-title":"Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody","volume":"411","author":"Rispens","year":"2011","journal-title":"Anal Biochem"},{"key":"2020022605560144500_B16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kex371","article-title":"IgG4-related disease presenting with raised serum IgG2-real timeline of IgG4-RD?","volume":"57","author":"Dunkley","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2020022605560144500_B17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/bjophthalmol-2017-310148","article-title":"Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): potential use in IgG4-RD assessment","volume":"101","author":"Chan","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"2020022605560144500_B18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.semarthrit.2017.03.021","article-title":"Disease associations with isolated elevations of each of the four IgG subclasses","volume":"47","author":"Engelhart","year":"2017","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/4\/735\/32641664\/clinchem0735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/4\/735\/32641664\/clinchem0735.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T11:03:57Z","timestamp":1582715037000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/64\/4\/735\/5608771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2017.282319","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4,1]]},"published":{"date-parts":[[2018,4,1]]}}}